BerandaAVH • ASX
add
AVITA Medical Inc
Tutup sebelumnya
$1,05
Rentang hari
$1,06 - $1,12
Rentang tahun
$1,00 - $4,40
Kapitalisasi pasar
164,64Â jt AUD
Volume Rata-Rata
282,78Â rb
Rasio P/E
-
Hasil dividen
-
Berita pasar
Kaltimtoday.co
22 jam yang lalu
Wall Street Tutup 2025 di Zona Merah, S&P 500 Naik 16,4% dalam Setahun
0,74%
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 17,06Â jt | -12,71% |
Biaya operasional | 23,03Â jt | -23,65% |
Penghasilan bersih | -13,19Â jt | 18,62% |
Margin laba bersih | -77,29 | 6,78% |
Penghasilan per saham | -0,71 | 23,47% |
EBITDA | -8,58Â jt | 36,43% |
Tarif pajak efektif | -0,11% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 23,31Â jt | -47,50% |
Total aset | 63,73Â jt | -21,37% |
Total liabilitas | 70,39Â jt | 2,28% |
Total ekuitas | -6,67 jt | — |
Saham yang beredar | 30,49 jt | — |
Harga terhadap nilai buku | -4,77 | — |
Tingkat pengembalian aset | -37,55% | — |
Tingkat pengembalian modal | -65,56% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -13,19Â jt | 18,62% |
Kas dari operasi | -5,22Â jt | 27,65% |
Kas dari investasi | -5,34Â jt | -172,23% |
Kas dari pembiayaan | 13,77Â jt | 1.267,03% |
Perubahan kas bersih | 3,21Â jt | 170,09% |
Arus kas bebas | -2,61Â jt | 51,24% |
Tentang
Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia. Wikipedia
Didirikan
1999
Kantor pusat
Situs
Karyawan
260
